Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA68970
Max Phase: Preclinical
Molecular Formula: C34H41FN4O7S
Molecular Weight: 668.79
Molecule Type: Small molecule
Associated Items:
ID: ALA68970
Max Phase: Preclinical
Molecular Formula: C34H41FN4O7S
Molecular Weight: 668.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H](C(=O)N[C@H]1CCc2cccc3c2N(C1=O)[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)CSCc1ccc(F)cc1)C3)N(C)C(C)=O
Standard InChI: InChI=1S/C34H41FN4O7S/c1-5-19(2)30(38(4)20(3)40)33(45)36-25-14-11-22-7-6-8-23-15-27(39(31(22)23)34(25)46)32(44)37-26(16-29(42)43)28(41)18-47-17-21-9-12-24(35)13-10-21/h6-10,12-13,19,25-27,30H,5,11,14-18H2,1-4H3,(H,36,45)(H,37,44)(H,42,43)/t19-,25-,26-,27-,30-/m0/s1
Standard InChI Key: JQBZFNPXCPETAI-VZLANYELSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 668.79 | Molecular Weight (Monoisotopic): 668.2680 | AlogP: 2.87 | #Rotatable Bonds: 14 |
Polar Surface Area: 153.19 | Molecular Species: ACID | HBA: 7 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.76 | CX Basic pKa: | CX LogP: 2.94 | CX LogD: -0.33 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.28 | Np Likeness Score: -0.28 |
1. Willoughby CA, Bull HG, Garcia-Calvo M, Jiang J, Chapman KT, Thornberry NA.. (2002) Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis., 12 (16): [PMID:12127536] [10.1016/s0960-894x(02)00363-3] |
Source(1):